Cargando…
Naringenin mitigates antituberculosis drugs induced hepatic and renal injury in rats
Tuberculosis is one of the deadly diseases, which can be well treated by antituberculosis drugs (ATDs) i.e. isoniazid, rifampicin, pyrazinamide and ethambutol. These drugs also lead to severe hepatic and renal injury. The present study was designed to investigate efficacy of naringenin against ATDs...
Autores principales: | Sahu, Nisha, Mishra, Gita, Chandra, Hemeshwer Kumar, Nirala, Satendra Kumar, Bhadauria, Monika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6957811/ https://www.ncbi.nlm.nih.gov/pubmed/31956555 http://dx.doi.org/10.1016/j.jtcme.2019.01.001 |
Ejemplares similares
-
Naringenin mitigates reserpine-induced anxiety-like behavior, neurodegeneration, and oxidative stress in male rats
por: Sadeghi Nejad, Zahra, et al.
Publicado: (2023) -
Pharmacokinetic Comparisons of Naringenin and Naringenin-Nicotinamide Cocrystal in Rats by LC-MS/MS
por: Xu, Dan, et al.
Publicado: (2020) -
Naringenin protects against isoniazid- and rifampicin-induced apoptosis in hepatic injury
por: Wang, Chao, et al.
Publicado: (2016) -
Effects of naringenin on the pharmacokinetics of tofacitinib in rats
por: Wang, Bo, et al.
Publicado: (2020) -
Genetic polymorphisms of N-acetyltransferase 2 & susceptibility to antituberculosis drug-induced hepatotoxicity
por: Sharma, Surendra K., et al.
Publicado: (2016)